Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

EF 2016-17

Résumé
Depression is a common mental disorder that affects more than 350 million people of all ages worldwide. Selective serotonin reuptake inhibitors (SSRIs) are a newer class of antidepressant drugs that are widely used to treat depression. In addition to their antidepressive effects, studies have shown that SSRIs may also act as a blood thinner by blocking the effect of serotonin on blood platelets, where serotonin normally activates clotting. The degree of this thinning effect is suggested to be linked to the relative affinity of the antidepressant to the serotonin transporter on blood platelets, whereby antidepressants with a higher affinity for the serotonin transporter may have a stronger thinning effect. In this study, we propose that among available antidepressants, those with a higher affinity for serotonin transporter may have a protective effect on the risk of myocardial infarction (MI), which often occurs due to blood clots that block blood flow to the heart. Using the UK Clinical Practice Research Datalink, one of the world's largest databases of computerized medical records, we will conduct a retrospective cohort study to compare the risk of MI between users of antidepressants with high affinity for the serotonin transporter and users of antidepressants with low affinity for the serotonin transporter. The results of this study will be invaluable for physicians to identify individuals that may benefit the most from antidepressants with high affinity for serotonin transporter and tailor depression treatment to individual patients' characteristics.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367393
Name
Yoon Sarah
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Depression; Myocardial Infarction; Pharmacoepidemiology; Selective Serotonin Reuptake Inhibitor
Abstract
Depression is a common mental disorder that affects more than 350 million people of all ages worldwide. Selective serotonin reuptake inhibitors (SSRIs) are a newer class of antidepressant drugs that are widely used to treat depression. In addition to their antidepressive effects, studies have shown that SSRIs may also act as a blood thinner by blocking the effect of serotonin on blood platelets, where serotonin normally activates clotting. The degree of this thinning effect is suggested to be linked to the relative affinity of the antidepressant to the serotonin transporter on blood platelets, whereby antidepressants with a higher affinity for the serotonin transporter may have a stronger thinning effect. In this study, we propose that among available antidepressants, those with a higher affinity for serotonin transporter may have a protective effect on the risk of myocardial infarction (MI), which often occurs due to blood clots that block blood flow to the heart. Using the UK Clinical Practice Research Datalink, one of the world's largest databases of computerized medical records, we will conduct a retrospective cohort study to compare the risk of MI between users of antidepressants with high affinity for the serotonin transporter and users of antidepressants with low affinity for the serotonin transporter. The results of this study will be invaluable for physicians to identify individuals that may benefit the most from antidepressants with high affinity for serotonin transporter and tailor depression treatment to individual patients' characteristics.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yoon, Sarah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~